Christophe M. Borg
Besancon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 238 publications
Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm phase II trial.
Journal: ESMO gastrointestinal oncology
Published: July 06, 2026
Metastatic or unresectable recurrent anal canal cancer: Therapeutic approaches and emerging perspectives
Journal: Bulletin du cancer
Published: March 30, 2026
Ezabenlimab with induction chemotherapy and adaptive chemoradiotherapy in stage 3 squamous cell anal carcinoma - Authors' reply.
Journal: The Lancet. Oncology
Published: January 12, 2026
ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté
Journal: Bulletin du cancer
Published: October 31, 2025
Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): Results from the GASPAR phase 2 study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 17, 2025
Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: August 08, 2025
Dynamic DNA methylation changes during colorectal oncogenesis with insights from adenoma stages.
Journal: Scientific reports
Published: June 20, 2025
Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors: A Secondary Analysis of the SAMCO-PRODIGE 54 Randomized Clinical Trial.
Journal: JAMA oncology
Published: June 18, 2025
Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL study.
Journal: Journal for immunotherapy of cancer
Published: April 14, 2025
Clinical and biological determinants of multimodal metronomic chemotherapy efficacy in chemo-refractory gastrointestinal cancers.
Journal: International journal of cancer
Published: March 30, 2025
Sensitive cell-free DNA assay for accurate detection of RAS and BRAF mutations in liquid biopsies of patients with metastatic colorectal cancer: Final results of the multicentric ColoBEAM study.
Journal: Oncology letters
Published: February 21, 2025
Bevacizumab-based chemotherapy adaptive to pharmacokinetic of bevacizumab in first-line treatment of patients with unresectable metastatic colorectal cancer: A double-blind, multicenter, randomized phase III trial study (PHARBEVACOL trial).
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: February 09, 2025
Last Updated: 09/26/2026